singulargenomics.com - OMIC Expected earnings per share growth for next year
Singular Genomics Systems (OMIC) is optimizing technical processes to reduce board defects, which is supported by the consensus estimate of net profit growth rates, where 0.00 is recorded as the baseline value. Business efficiency is based on contract electronics manufacturing and external logistics. Simultaneously, the R&D center is developing the G4 platform and automating genome analysis, strengthening the company's technological foundation.
Analytical breakdowns for singulargenomics.com (OMIC)
- price and consensus price forecast:
- issuer market value details:
- book capitalization information:
- company total debt and liquidity indicators:
Debt to Equity Singular Genomics Systems|OMIC - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Singular Genomics|OMIC - Company Cumulative Debt|Debt to Book Capitalization Ratio Singular Genomics|OMIC - Company Long-Term Liabilities|Company Short-Term Debts Singular Genomics|Quick Ratio singulargenomics.com
- earnings and valuation multiples information:
OMIC - Net Income|Expected Profit Singular Genomics Systems|OMIC - Business Payback Period|Projected Price to Earnings Singular Genomics Systems|OMIC - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Singular Genomics|OMIC - Operating income before deduction of amortization|Net earnings per share for the last 12 months Singular Genomics|OMIC - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months singulargenomics.com|OMIC - Expected net earnings per share growth this year|Expected earnings per share growth for next year Singular Genomics Systems
Fundamental company analysis:OMIC, Singular Genomics Systems Inc
The scaling of robotic genome sequencing systems directly impacts current expectations for the EPS n+1 growth rate, reflecting the commercial success of laboratory automation for Singular Genomics Systems (OMIC). This indicator aggregates analyst consensus forecasts for next year's profit dynamics, where a smooth upward trend confirms the resilience of the business model, while high curve volatility signals fundamental risks and earnings uncertainty.
Analysis of competing companies
Net earnings per share growth forecast for next year Tempus AI, Inc|QGEN: Expected earnings per share trend next year|Expected earnings per share growth for next year IONS (Ionis Pharmaceuticals)|RGEN (repligen.com) - Expected earnings per share trend next year|Earnings growth forecast for next year RNA (Avidity Biosciences, Inc.)|Net earnings per one share growth forecast for next year CRISPR Therapeutics Inc|Sema4 - Earnings growth forecast for next year|Expected net earnings per share growth next year Ultragenyx Corp|Beam Therapeutics Inc. (BEAM) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year SRPT|Net earnings per share growth forecast for next year Twist Bioscience, Inc.|Expected net earnings per share growth next year 10x Genomics Inc TXG|Net earnings per share growth forecast for next year Intellia (NTLA)|Expected earnings per share growth for next year Stoke Corp STOK|Earnings growth forecast for next year BLFS (BioLife Solutions, Inc.)|Consensus forecast of earnings per share growth for next year wavelifesciences.com (WVE)|Maze Therapeutics - Earnings growth forecast for next year|Sionna Therapeutics, Inc. (SION) - Expected earnings per share growth for next year|Prime Medicine Corp (PRME) - Net earnings per share growth forecast for next year|TSHA - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year QURE|MGTX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year REGENXBIO (RGNX)|Consensus forecast of earnings per share growth for next year Solid Biosciences Inc|Ocugen Corp - Expected earnings per share growth for next year|PacBio Corp (PACB) - Expected net earnings per share growth next year|BNTC - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year designtx.com DSGN|RCKT (Rocket Pharmaceuticals, Inc.) - Expected earnings per share growth for next year|FDMT: Projected earnings per share increase next year|LXEO (Lexeo Therapeutics Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Korro Bio, Inc KRRO|Net earnings per share growth forecast for next year Editas Medicine, Inc. (EDIT)|Expected earnings per share growth for next year silence-therapeutics.com SLN|Net earnings per share growth forecast for next year ProQR Therapeutics PRQR|Consensus forecast of earnings per share growth for next year Codexis Inc (CDXS)|SGMO - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Nautilus Biotechnology|Metagenomi, Inc. (MGX) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Precision BioSciences Inc.|GBIO (Generation Bio Co) - Earnings growth forecast for next year|Boundless Bio Inc. (BOLD) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year XCUR|Expected earnings per share growth for next year imunon.com IMNN|Earnings growth forecast for next year PHIO (Phio Pharmaceuticals Corp.)|MBIO: Projected earnings per share growth rate for next year|RNAZ - Net earnings per share growth forecast for next year|BNGO (Bionano Genomics, Inc.) - Projected earnings per share growth rate for next year|APDN: Earnings growth forecast for next year|bluebird bio, Inc (BLUE) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year ImmunoPrecise Antibodies Ltd|omegatherapeutics.com (OMGA) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year RGLS|Consensus forecast of earnings per share growth for next year Syros Pharmaceuticals Inc.|Net earnings per share growth forecast for next year Codex DNA TBIO|TCON: Projected earnings per share growth rate for next year|Unity Biotechnology - Earnings growth forecast for next year
